Ezetimibe and Flecainide acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Flecainide acetate (flecainide acetate). Common drug interactions include diarrhoea among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Flecainide acetate. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.



On Jul, 26, 2026

28 people who take Ezetimibe and Flecainide acetate together, and have interactions are studied.

Ezetimibe and Flecainide acetate drug interactions.

What are the common drug interactions of Ezetimibe and Flecainide Acetate, by gender? *:

female:

  1. Diarrhoea
  2. Abdominal pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Drug hypersensitivity
  5. Gastroenteritis (inflammation of stomach and intestine)
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Nausea (feeling of having an urge to vomit)
  9. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  10. Prurigo (chronic skin disease causing severe itching)

male:

  1. Dizziness
  2. Pneumonia
  3. Hyperhidrosis (abnormally increased sweating)
  4. Myalgia (muscle pain)
  5. Neoplasm malignant (cancer tumour)
  6. Vertigo
  7. Corneal oedema (corneal swelling)
  8. Hypotension (abnormally low blood pressure)
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Cough

What are the common drug interactions of Ezetimibe and Flecainide Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Diarrhoea
  2. Abdominal pain
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Campylobacter gastroenteritis (infection of gastrointestinal system)
  5. Campylobacter infection (infection by the campylobacter bacterium)
  6. Nausea (feeling of having an urge to vomit)
  7. Viral infection

60+:

  1. Diarrhoea
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Feeling drunk
  5. Hyperhidrosis (abnormally increased sweating)
  6. Neoplasm malignant (cancer tumour)
  7. Vertigo
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Corneal oedema (corneal swelling)
  10. Cough

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 14.29%
  2. High Blood Pressure: 4 people, 14.29%
  3. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 14.29%
  4. Weakness: 3 people, 10.71%
  5. Sleep Apnea Syndrome: 3 people, 10.71%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 10.71%
  7. Drowsiness: 3 people, 10.71%
  8. Arrhythmias (irregular heartbeat): 3 people, 10.71%
  9. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 7.14%
  10. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Flecainide acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ezetimibe and Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flecainide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe and flecainide acetate (the active ingredients of Ezetimibe and Flecainide acetate, respectively), and Ezetimibe and Flecainide acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: